Hyperhomocysteinemia Activates the Aryl Hydrocarbon Receptor‐CD36 Pathway to Promote Hepatic Steatosis in Mice

In conclusion, our results strongly suggest that HHcy activated the AHR‐CD36 pathway by increasing hepatic LXA4 content, which resulted in hepatic steatosis. This article is protected by copyright. All rights reserved.

Source: Hepatology - February 29, 2016 Category: Internal Medicine Authors: Liu Yao, Chunjiong Wang, Xu Zhang, Liyuan Peng, Wenli Liu, Xuejiao Zhang, Yajin Liu, Jinlong He, Changtao Jiang, Ding Ai, Yi Zhu Tags: Steatohepatitis and Metabolic Liver Disease Source Type: research